This inventor holds 11 USPTO granted patents. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stevenage, GB (2007)
- Harlow, GB (2006 - 2009)
Company Filing History:
Years Active: 2006-2009
Title: The Innovative Contributions of Nigel Paul King
Introduction
Nigel Paul King is a prominent inventor based in Harlow, GB, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable advancements in the development of medical compounds.
Latest Patents
Among his latest patents, King has developed pyrrolidine derivatives as factor Xa inhibitors. This invention relates to compounds that are crucial in the preparation of pharmaceutical compositions aimed at ameliorating clinical conditions where a Factor Xa inhibitor is indicated. Additionally, he has created imidazotriazine compounds, which provide pharmaceutical agents through defined processes for their preparation and use.
Career Highlights
Throughout his career, Nigel Paul King has worked with notable companies such as Glaxo Group Limited and SmithKline Beecham Corporation. His work in these organizations has contributed to the advancement of pharmaceutical research and development.
Collaborations
King has collaborated with esteemed colleagues, including Vipulkumar Kantibhai Patel and Chuen Chan, further enhancing the innovative efforts in his field.
Conclusion
Nigel Paul King stands out as a significant figure in pharmaceutical innovation, with a strong portfolio of patents that reflect his dedication to improving medical treatments. His contributions continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile